AstraZeneca Boosts EU Vaccine Supply

About This Source - Bloomberg Markets and Finance

Bloomberg Markets and Finance features news about financial markets from around the world. Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City. It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Bloomberg Books #Ad

Recent from Bloomberg Markets and Finance:

  • How Engine No. 1 Took on Exxon
  • India, Singapore an Alternative to China: Credit Suisse’s Fineman
  • Delta Cases Rise in Mainland China
  • Bloomberg Markets and Finance published this video item, entitled “AstraZeneca Boosts EU Vaccine Supply” – below is their description.

    Feb.01 — European Parliament Committee on Environmental and Public Health Chair Pascal Canfin discusses the EU’s vaccination drive, AstraZeneca Plc. boosting its vaccine supply and the challenges the EU faces in distribution. He speaks on “Bloomberg Markets: European Open.”

    Bloomberg Markets and Finance YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • COVID-19 update 2 August – Brisbane and Sydney in lockdown, Melbourne, SA easing | News Breakfast
  • Vaccine targets depend on strong ‘take-up’ of AstraZeneca | Coronavirus | 9 News Australia
  • AstraZeneca developer says mixed messaging on vaccine in Australia may cause ‘lives lost’ | ABC News
  • Leave a Comment